Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6574637 | 1.00 | TSHR (0.65) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL4200709 | 0.90 | TSHR (0.53) | TSHRSMN1; SMN2KMT2AHPGDALDH1A1 | |
| SCHEMBL16379302 | 0.90 | TSHR (0.53) | TSHRSMN1; SMN2KMT2AHPGDALDH1A1 | |
| SCHEMBL30423678 | 0.88 | FAAH (0.52) | TSHRKMT2AHPGDALDH1A1CYP2C9 | |
| SCHEMBL18300369 | 0.86 | TSHR (0.57) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL25842763 | 0.84 | TSHR (0.51) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL8224624 | 0.84 | SMN1; SMN2 (0.60) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL29006983 | 0.84 | TSHR (0.58) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL265567 | 0.84 | SMN1; SMN2 (0.60) | TSHRSMN1; SMN2KMT2AMEN1HTT | |
| SCHEMBL29232860 | 0.84 | TSHR (0.58) | TSHRSMN1; SMN2KMT2AMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| EP-4602141-A1 | A FRAGRANCE MIXTURE (VI) | Symrise AG (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4532646-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-04-09 | — | — | EP | claimed |
| US-20250099349-A1 | A FRAGRANCE MIXTURE | SYMRISE AG (DE) | 2025-03-27 | — | — | US | claimed |
| EP-4519403-A1 | A FRAGRANCE MIXTURE (V) | Symrise AG (DE) | 2025-03-12 | — | — | EP | claimed |
| EP-4473079-A1 | A FRAGRANCE MIXTURE | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-4472606-A1 | COMPOSITIONS (III) | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| US-20240358611-A1 | COMPOSITIONS | SYMRISE AG (DE) | 2024-10-31 | — | — | US | claimed |
| EP-4429465-A1 | COMPOSITIONS COMPRISING TRPM8 AGONISTIC COOLING AGENTS | Symrise AG (DE) | 2024-09-18 | — | — | EP | claimed |
| EP-4387587-A1 | COMPOSITIONS | Symrise AG (DE) | 2024-06-26 | — | — | EP | claimed |
| US-8962057-B2 | Methods for improving taste and oral care compositions with improved taste | THE PROCTER & GAMBLE COMPANY (US) | 2015-02-24 | — | — | US | claimed |
| EP-2424621-A2 | METHODS FOR IMPROVING TASTE AND ORAL CARE COMPOSITIONS WITH IMPROVED TASTE | The Procter & Gamble Company (US) | 2012-03-07 | — | — | EP | claimed |
| US-20110118217-A1 | Agonists for Antimicrobial Peptide Systems | AKTHELIA PHARMACEUTICALS (IS) | 2011-05-19 | — | — | US | claimed |
| US-20110105544-A1 | CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2011-05-05 | — | — | US | claimed |
| CN-101959429-A | Agonists of antimicrobial peptide systems | AKTHELIA PHARMACEUTICALS | 2011-01-26 | — | — | CN | claimed |
| WO-2010126753-A2 | METHODS FOR IMPROVING TASTE AND ORAL CARE COMPOSITIONS WITH IMPROVED TASTE | THE PROCTER & GAMBLE COMPANY (US) | 2010-11-04 | — | — | WO | claimed |
| US-20100278991-A1 | Methods for Improving Taste and Oral Care Compositions With Improved Taste | THE PROCTER & GAMBLE COMPANY | 2010-11-04 | — | — | US | claimed |
| EP-2237684-A2 | AGONISTS FOR ANTIMICROBIAL PEPTIDE SYSTEMS | Akthelia Pharmaceuticals (IS) | 2010-10-13 | — | — | EP | claimed |
| WO-2009087474-A2 | AGONISTS FOR ANTIMICROBIAL PEPTIDE SYSTEMS | AKTHELIA PHARMACEUTICALS (IS) | 2009-07-16 | — | — | WO | claimed |
| WO-2009080722-A2 | CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2009-07-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358611-A1 | COMPOSITIONS | AZI2, NISCH, CIP2A | TSHR 4086/4885SMN1; SMN2 955/4885KMT2A 617/4885 |
| US-20110118217-A1 | Agonists for Antimicrobial Peptide Systems | VIP, GLP1R, MAVS | TSHR 2225/4885SMN1; SMN2 3320/4885KMT2A 4643/4885 |
| US-20250099349-A1 | A FRAGRANCE MIXTURE | PTMS, EP300, TRPA1 | TSHR 4083/4885SMN1; SMN2 4713/4885KMT2A 804/4885 |
| US-20110105544-A1 | CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | AKR1C3, TPD52L2, HCCS | TSHR 1505/4885SMN1; SMN2 2869/4885KMT2A 2127/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | TSHR 2980/4885SMN1; SMN2 1800/4885KMT2A 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.